| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.071 | 0.2 |